Incidence and survival in late liver metastases of colorectal cancer

Journal of Gastroenterology and Hepatology (Australia)

Volumn 30, Issue 1, 2015, Pages 82-85

  Landreau, Pierre ^a   Drouillard, Antoine ^b   Launoy, Guy ^c   Ortega Deballon, Pablo ^a   Jooste, Valérie ^b   Lepage, Côme ^b   Faivre, Jean ^b   Facy, Olivier ^a   Bouvier, Anne Marie ^b  

^a DIJON UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE BOURGOGNE   (France)

^c CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

Cancer registry; Colorectal cancer; Incidence; Long term liver metastasis; Survival

Indexed keywords

AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PATIENT; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CANCER; FEMALE; HAZARD RATIO; HUMAN; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; SEX DIFFERENCE; COLORECTAL NEOPLASMS; INCIDENCE; LIVER NEOPLASMS; MORTALITY; PATHOLOGY; RISK; SECONDARY; SURVIVAL RATE; TIME;

COLORECTAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; LIVER NEOPLASMS; MALE; NEOPLASM STAGING; RISK; SURVIVAL RATE; TIME FACTORS;

EID: 84919691602     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12685     Document Type: Article

References (18)

1. Institut de veille sanitaire. Projection de l'incidence et de la mortalité par cancer en France en 2011. 2011. Cited 2011. Available from URL: http://www.invs.sante.fr
2. Neo EL, Beeke C, Price T etal. South Australian clinical registry for metastatic colorectal cancer. ANZ. J. Surg. 2011; 81: 352-357.
3. Wang X, Hershman DL, Abrams JA etal. Predictors of survival after hepatic resection among patients with colorectal liver metastasis. Br. J. Cancer 2007; 97: 1606-1612.
4. Fritz A, Percy C, Jack A etal. International Classification of Diseases for Oncology, 3rd edn. Geneva: World Health Organization, 2000.
5. In: Wittekind C, Wagner G, Springer, eds. Colon and rectum. In TNM-. In: Springer, ed. Classification of Malignant Tumors. New York: Springer, 1997; 64-67.
6. Leporrier J, Maurel J, Chiche L, Bara S, Segol P, Launoy G. A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer. Br. J. Surg. 2006; 93: 465-474.
7. Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, Bouvier AM. Epidemiology and management of liver metastases from colorectal cancer. Ann. Surg. 2006; 244: 254-259.
8. Rees M, Tekkis PP, Welsh FK, O'Rourke T, John TG. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann. Surg. 2008; 247: 125-135.
9. Taylor I, Mullee MA, Campbell MJ. Prognostic index for the development of liver metastases in patients with colorectal cancer. Br. J. Surg. 1990; 77: 499-501.
10. Norstein J, Silen W. Natural history of liver metastases from colorectal carcinoma. J. Gastrointest. Surg. 1997; 1: 398-407.
11. Labianca R, Nordlinger B, Beretta GD, Brouquet A, Cervantes A. Primary colon cancer: ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up. Ann. Oncol. 2010; 21 Suppl 5: v70-77.
12. Glimelius B, Pahlman L, Cervantes A. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2010; 21 (Suppl. 5): v82-86.
13. SNFGE. National thesaurus of digestive oncology. 2010. [cited; available from: http://www.snfge.asso.fr/01-bibliotheque/0g-thesaurus-cancerologie/publication5/sommaire-thesaurus.asp]
14. Holt PR, Kozuch P, Mewar S. Colon cancer and the elderly: from screening to treatment in management of GI disease in the elderly. Best Pract. Res. Clin. Gastroenterol. 2009; 23: 889-907.
15. Folprecht G, Seymour MT, Saltz L etal. Irinotecan/fluorouracil combination in first-line therapy of older and younger patients with metastatic colorectal cancer: combined analysis of 2, 691 patients in randomized controlled trials. J. Clin. Oncol. 2008; 26: 1443-1451.
16. Mann CD, Neal CP, Pattenden CJ etal. Major resection of hepatic colorectal liver metastases in elderly patients-an aggressive approach is justified. Eur. J. Surg. Oncol. 2008; 34: 428-432.
17. Nordlinger B, Sorbye H, Glimelius B etal. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 2008; 371: 1007-1016.
18. Kopetz S, Chang GJ, Overman MJ etal. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J. Clin. Oncol. 2009; 27: 3677-3683.